Agilent Technologies Combines Its Life Sciences And Diagnostics Businesses; Lars Holmkvist Named Group President
Agilent Technologies Inc. (NYSE: A) today announced it has combined its
Life Sciences Group with its Diagnostics and Genomics business, naming
Lars Holmkvist the new group’s president and senior vice president of
Agilent Technologies Inc. (NYSE: A) today announced it has combined its Life Sciences Group with its Diagnostics and Genomics business, naming Lars Holmkvist the new group’s president and senior vice president of Agilent, effective immediately. Holmkvist was previously president of the Diagnostics and Genomics Group and senior vice president of Agilent. This organizational decision follows Agilent’s announcement earlier today that it plans to separate the company into two independent publicly traded companies – one focused on life sciences, diagnostics and applied markets, retaining the Agilent name, and the other focused on electronic measurement, which will be named later. Agilent, the life sciences, diagnostics and applied markets company, will be comprised of two businesses – the Chemical Analysis Group, led by Mike McMullen, current group president and Agilent senior vice president, and the new Life Sciences and Diagnostics Group, under Holmkvist as its president. Nick Roelofs, who has been president of the Life Sciences Group, will leave Agilent to pursue other business opportunities. “We are creating a new Agilent with a simplified structure that can move quickly to develop and deliver industry-leading total workflow solutions for our customers,” said William (Bill) Sullivan, Agilent president and CEO. “Lars is the ideal leader for the new group with his years of experience, depth of market knowledge and superb leadership style.” Agilent also announced that with the spinoff of its electronic measurement business, it has created a new Agilent Order Fulfillment organization. Henrik Ancher-Jensen has been named president of Agilent Order Fulfillment and senior vice president of Agilent. He replaces Gooi Soon Chai, who is joining the electronic measurement spinoff company. Ancher-Jensen was previously vice president, Global Product Supply, for Agilent’s Diagnostics and Genomics Group, and corporate vice president, Global Operations, for Dako. “Henrik understands the priority of customer satisfaction while at the same time contributing to margin expansion goals. His experience and drive for excellence makes him a great match for this important position,” Sullivan said.